Summary
Highlights
Peptides are becoming popular in Silicon Valley, promising various benefits like fat burning, improved focus, and better sleep. These unregulated drugs, often sourced from China, are gaining traction among both tech insiders and a broader 'normie' audience, raising questions about their safety and efficacy.
Peptides are amino acid chains found naturally in the body (like insulin) but those discussed here are synthetically produced and injected. While some, like GLP-1 drugs (Ozempic), are legal, a wide range of experimental and off-label peptides are circulating. There's limited scientific understanding of their effects, but users hope for muscle repair, wrinkle reduction, improved focus, and better sleep.
Most peptides are unregulated and understudied. Reporter Ezra Marcus describes his experience sourcing peptides: buying from a regulated med spa for NAD+, and then more experimental Retatrutide from a Chinese factory representative via Discord for a fraction of the cost, labeled 'for research purposes only'.
Jasmine Sun explains that peptides became a viral meme in San Francisco tech culture, with people comparing their use to beta testing new software. Tori Pastore shares her personal journey, being prescribed Ozempic but turning to unregulated Chinese sources due to cost, experiencing severe side effects but believing the results were worth it. She also discusses trying copper peptides for skin, hair, and nails.
Max Marchione, co-founder of Superpower, believes peptides will become a 'trillion-dollar category', leading to a 'Pharma 2.0' where injections are a viable drug delivery method. He sees them as a fringe trend moving mainstream, emphasizing that many smart biologists and doctors are already using them, but also warns against blindly taking them from unsupervised sources.
Cardiologist Eric Topol expresses strong skepticism, stating there's no scientific evidence or clinical trials to prove the benefits of these unregulated peptides. He argues that without proper testing, users cannot be sure of safety, efficacy, or even if they are receiving a placebo, especially at high costs. He calls the claims 'bro science' and not factual.
The widespread appeal of peptides reflects a growing willingness to spend money on self-improvement and a decreasing trust in traditional medical establishments. Users, influenced by images of 'perfect' individuals, are willing to take risks, ordering unregulated substances from online sources and self-administering them, believing the potential benefits outweigh the unknown risks.